标普和纳斯达克内在价值 联系我们

Spero Therapeutics, Inc. SPRO NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
61/100
2/7 Pass
SharesGrow Intrinsic Value
$7.22
+173.5%

Spero Therapeutics, Inc. (SPRO) has 20 已知的内部人和机构持有人记录. 最大持有人为 GSK PLC 持有 9,190,606 股. 其他重要持有人包括 Aquilo Capital, L.P. 和 Aquilo Capital Management, LLC.

过去12个月,内部人进行了 18 笔交易,涉及 SPRO 股票 — 11 笔买入 (价值为 $1.42M) 和 7 笔卖出 (价值为 $335.28K). 内部人买入超过卖出,可能表明对公司前景有信心.

SPRO 內部人持股

最大持股人
GSK PLC
9,190,606 股
买入(12个月)
11
$1.42M 价值
卖出(12个月)
7
$335.28K 价值
12个月交易活动
买入 61%
卖出 39%
主要內部人持股
# 姓名 职位 持股数量 最近申报日期 相对规模
1 Gsk Plc Director 9,190,606 2022-11-14
100%
2 Aquilo Capital, L.p. Director 5,321,231 2022-04-28
58%
3 Aquilo Capital Management, Llc 10 Percent Owner 3,419,435 2022-09-26
37%
4 Glaxosmithkline Plc 10 Percent Owner 1,934,006 2018-07-17
21%
5 Shukla Sath CEO & President 1,892,216 2025-02-05
21%
6 Graham Holdings Co 10 Percent Owner 1,428,094 2015-11-02
16%
7 Rajavelu Esther See Remarks 1,012,091 2026-02-09
11%
8 Hamed Kamal Chief Medical Officer 816,192 2024-02-05
9%
9 Keutzer Timothy Chief Operating Officer 742,506 2026-02-09
8%
10 Mahadevia Ankit Director 703,294 2025-09-03
8%
11 Joseph Tamara L Chief Legal Officer 562,521 2024-02-05
6%
12 Deshpande Milind Director 91,454 2025-06-16
1%
13 Thomas Frank E Director 75,000 2025-06-16
1%
14 Pottage John C Jr Director 75,000 2025-06-16
1%
15 Vink Patrick V.j.j. Director 75,000 2025-06-16
1%
16 Tregoning Kathleen Director 75,000 2025-06-16
1%
17 Smith Cynthia Director 75,000 2025-06-16
1%
18 Jackson Scott Thomas Director 75,000 2025-06-16
1%
19 Sendek Joel Chief Financial Officer 65,000 2019-01-02
1%
20 Melnick David A. Chief Medical Officer 53,190 2022-02-03
1%
近期交易 (过去12个月)
日期 姓名 职位 类型 股数 股价 总价值
2026-02-06 Rajavelu Esther See Remarks 知情卖出 50,816 $2.36 $119.93K
2026-02-06 Keutzer Timothy Chief Operating Officer 知情卖出 18,652 $2.36 $44.02K
2026-02-04 Keutzer Timothy Chief Operating Officer 知情卖出 3,471 $2.24 $7.78K
2026-02-03 Keutzer Timothy Chief Operating Officer 知情卖出 24,224 $2.14 $51.84K
2026-02-02 Keutzer Timothy Chief Operating Officer 限制性股票授予 (RSU) 137,000 $2.23 $305.51K
2026-02-02 Rajavelu Esther See Remarks 限制性股票授予 (RSU) 498,000 $2.23 $1.11M
2025-11-07 Rajavelu Esther See Remarks 知情卖出 40,270 $2.37 $95.44K
2025-08-28 Keutzer Timothy Chief Operating Officer 知情卖出 1,695 $1.97 $3.34K
2025-08-28 Mahadevia Ankit Director 知情卖出 6,572 $1.97 $12.95K
2025-06-12 Tregoning Kathleen Director 限制性股票授予 (RSU) 20,000 - -
2025-06-12 Mahadevia Ankit Director 限制性股票授予 (RSU) 20,000 - -
2025-06-12 Smith Cynthia Director 限制性股票授予 (RSU) 20,000 - -
2025-06-12 Jackson Scott Thomas Director 限制性股票授予 (RSU) 20,000 - -
2025-06-12 Vink Patrick V.j.j. Director 限制性股票授予 (RSU) 20,000 - -
2025-06-12 Deshpande Milind Director 限制性股票授予 (RSU) 20,000 - -
2025-06-12 Pottage John C Jr Director 限制性股票授予 (RSU) 20,000 - -
2025-06-12 Thomas Frank E Director 限制性股票授予 (RSU) 20,000 - -
2025-05-02 Rajavelu Esther See Remarks 限制性股票授予 (RSU) 185,000 - -
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言